Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G Peters

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Frontiers in Immunology|July 11, 2025
Nanolipoprotein particle (NLP) vaccine confers protection against <i>Yersinia pestis</i> aerosol challenge in a BALB/c mouse modelSergei S Biryukov, Amy Rasley, Michael L Davies, et al.
Frontiers in Immunology|January 21, 2026
An mRNA vaccine encoding the Ebola virus glycoprotein induces high neutralizing antibody titers and provides strong protection against lethal infections in mouse modelsZachary R Stromberg, Elvia E Silva, Sara C Johnston, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Frontiers in Immunology|July 11, 2025
Nanolipoprotein particle (NLP) vaccine confers protection against <i>Yersinia pestis</i> aerosol challenge in a BALB/c mouse modelSergei S Biryukov, Amy Rasley, Michael L Davies, et al.
Frontiers in Immunology|January 21, 2026
An mRNA vaccine encoding the Ebola virus glycoprotein induces high neutralizing antibody titers and provides strong protection against lethal infections in mouse modelsZachary R Stromberg, Elvia E Silva, Sara C Johnston, et al.
Pageof 6